Miltenyi Biotec Acquires Owl Biomedical, Inc.

News   Apr 29, 2013

 
Miltenyi Biotec Acquires Owl Biomedical, Inc.
 
 
 

RELATED ARTICLES

New Cell Therapy for Diabetes Being Tested

News

The University of British Columbia and Vancouver Coastal Health are testing a possible diabetes cure that replaces a person’s damaged pancreatic cells with new ones grown in the lab.

READ MORE

Fast-tracking T Cell Therapies with Immune-mimicking Biomaterials

News

A new approach to amplify patient-specific T cells outside the body could increase the efficiency of cancer immunotherapies.

READ MORE

Researchers Create Remote-Controlled Cancer Immunotherapy System

News

A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE